Drastic cancer drug price drop to benefit patients


KUALA LUMPUR: The price of the costly trastuzumab, a breast cancer drug for HER2-positive patients has dropped by more than half in the tender to the Health Ministry, resulting in more patients expected to be treated in the ministry hospitals.

According to industry sources, the originator pharmaceutical company has dropped the price of the drug by about 52% in a tender approved by the ministry after a local drug company brought in a biosimilar version of the drug – the first in Malaysia – that costs about 50% of the original price.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 53
Cxense type: NA
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Nation

Muhyiddin: Mobilisation of LCS project expected to be completed by year-end
Perak police place 2,401 personnel on standby for floods
Witness: Issuance of LOS for US$3bil loan for 1MDB done in haste
Floods: 2,401 police personnel on standby in Perak
Saifuddin chairs coordination meeting to deal with job scam syndicates
No holiday in Johor for Sukma win, says State Secretary
Undocumented workers nabbed in Juru while fleeing Immigration raid
Police: Kidnap bid on Ipoh schoolgirl is fake
Naval cadet officer needed help showering, Coroner's Court hears
Felda Pemanis settlers finally get land ownership

Others Also Read